Suppr超能文献

治疗前活检的基因表达分析可预测食管鳞癌对新辅助放化疗的病理反应。

Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Guangdong Esophageal Cancer Institute, Guangzhou.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Guangdong Esophageal Cancer Institute, Guangzhou; Department of Thoracic Oncology.

出版信息

Ann Oncol. 2014 Sep;25(9):1769-1774. doi: 10.1093/annonc/mdu201. Epub 2014 Jun 6.

Abstract

BACKGROUND

Neoadjuvant chemoradiotherapy (neo-CRT) followed by surgery has been shown to improve esophageal squamous cell carcinoma (ESCC) patients' survival compared with surgery alone. However, the outcomes of CRT are heterogeneous, and no clinical or pathological method can currently predict CRT response. In this study, we aim to identify mRNA markers useful for ESCC CRT-response prediction.

PATIENTS AND METHODS

Gene expression analyses were carried out on pretreated cancer biopsies from 28 ESCCs who received neo-CRT and surgery. Surgical specimens were assessed for pathological response to CRT. The differentially expressed genes identified by expression profiling were validated by real-time quantitative polymerase chain reaction (qPCR), and a classifying model was built from qPCR data using Fisher's linear discriminant analysis. The predictive power of this model was further assessed in a second set of 32 ESCCs.

RESULTS

The profiling of the 28 ESCCs identified 10 differentially expressed genes with more than a twofold change between patients with pathological complete response (pCR) and less than pCR (<pCR). A prediction model based on the qPCR values of three genes was generated, which provided a predictive accuracy of 86% upon leave-one-out cross-validation. Furthermore, the predictive power of this model was validated in another cohort of 32 ESCCs, among which a predictive accuracy of 81% was achieved. Importantly, the discriminant score was found to be the only independent factor that affected neo-CRT response in both the training (P = 0.015) and validation (P = 0.017) sets, respectively.

CONCLUSION

The expression levels of three genes determined by qPCR provide a possible model for ESCC CRT prediction, which will facilitate the individualization of ESCC treatment. Further prospective validation in larger independent cohorts is necessary to fully assess its predictive power.

摘要

背景

新辅助放化疗(neo-CRT)后手术与单独手术相比,可提高食管鳞癌(ESCC)患者的生存率。然而,CRT 的疗效存在异质性,目前尚无临床或病理方法可预测 CRT 反应。本研究旨在确定用于预测 ESCC CRT 反应的 mRNA 标志物。

患者和方法

对 28 例接受 neo-CRT 和手术的 ESCC 患者的预处理癌活检进行基因表达分析。对手术标本进行 CRT 病理反应评估。通过表达谱鉴定出差异表达的基因,通过实时定量聚合酶链反应(qPCR)进行验证,并使用 Fisher 线性判别分析从 qPCR 数据构建分类模型。该模型的预测能力在第二组 32 例 ESCC 中进一步评估。

结果

对 28 例 ESCC 的分析确定了 10 个差异表达基因,这些基因在病理完全缓解(pCR)患者和 pCR 患者之间的表达水平相差两倍以上(pCR)。基于三个基因的 qPCR 值生成预测模型,该模型在留一法交叉验证中提供了 86%的预测准确性。此外,该模型的预测能力在另一组 32 例 ESCC 中得到验证,其中预测准确率为 81%。重要的是,判别得分是两个队列中唯一独立影响 neo-CRT 反应的因素(分别在训练组 P = 0.015 和验证组 P = 0.017)。

结论

qPCR 测定的三个基因的表达水平为 ESCC CRT 预测提供了一个可能的模型,这将有助于 ESCC 治疗的个体化。在更大的独立队列中进行进一步的前瞻性验证,以充分评估其预测能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验